The global microfluidics market size was valued at US$ 20 billion in 2022 and is expected to reach US$ 81.26 billion by 2032 with a CAGR of 15.1% from 2023 to 2032.
Key Takeaways
- North America led the global market with the highest market share of 43% in 2022.
- By Material, the polydimethylsiloxane (PDMS) segment is estimated to hold the highest market share of 34.5% in 2022.
- By Technology, the medical technology segment has held the biggest revenue share of 83% in 2022.
- By Application, the lab-on-a-chip segment had the largest market share of 38% in 2022.
Microfluidics refers to the science of controlling and manipulating fluids, commonly in the range of microliters (10-6) to picoliters (10-12), in networks of channels having dimensions ranging from tens to hundreds of micrometers. This discipline was originated in the early 1990’s and since then has been growing exponentially. It is analyzed as an essential tool for the life science research or in other significant researches in the field of biotechnologies. Because of the low volumes required, microfluidic technologies emerged as a promising alternative over the conventional laboratory techniques.
Microfluidics is mostly used and described in “organ on a chip” and “lab on a chip” technologies. However, it can be applied in a wide range of applications that includes pharmaceuticals (drug discovery), cosmetics (emulsions & formulations), chemistry (flow synthesis & stoichiometry), health (personalized medicine & diagnosis), energy (EOR models plasma confinement), and biology (cell culture and 3D printing).
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1116
Growth Factors
Rising demand for Point of Care (POC) testing in a wide range of applications because of the benefits associated with the incorporation of microfluidics along with high return on investments anticipated to propel the market growth of microfluidics during the analysis period. In addition, high-throughput screening methodologies, low-volume sample analysis, and increased demand for in vitro diagnostics (IVD) expected to offer numerous growth opportunities for the players operating in the microfluidics market during the forthcoming years. On the contrary, lack of market visibility for the microfluidics products coupled with high prices of the microfluidics sensors and integrated systems is the key factor that restrict the market growth.
Microfluidics has been successfully applied for the manufacturing of a diverse range of commercial products. For example, integrated fluidic circuits designed by the Fluidigm Corporation offers sample throughput that is comparatively high and provides cost-effective solutions for multiplex single-nucleotide polymorphism genotyping. Likewise, another manufacturer named Quanta Life that provides droplet-based microfluidic solutions for carrying out digital PCR for quantification of nucleic acids.
Caliper Life Sciences offers LabChip systems that use a glass microfluidic chip to receive a high-throughput fluorescent and electrophoretic analysis of protein fragments and nucleic acid. Further, technological advancement is the key factor that drives the market growth. For instance, organ-on-chips are the microfluidic devices that are used for culturing living cells in constantly perfused and micrometer-sized chambers to model physiological functions of tissues and organs.
Microfluidics Market Scope
| Report Highlights | Details |
| Growth Rate from 2023 to 2032 | CAGR of 15.1% |
| Market Size in 2023 | USD 22.92 Billion |
| Market Size by 2032 | USD 81.26 Billion |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Material, Technology, Application, Region |
Regional Snapshots
North America holds the largest value share in the global market for microfluidics. The growth of the region is mainly attributed to better reimbursement policies, well-established healthcare system, and the higher adoption of novel therapeutics among the common population.
Microfluidics is an enormously growing medical segment particularly in the United States in terms of investment on the Research & Development (R&D) for advancement in the microfluidic devices that further impel the growth of the market value. Further, the field of Point-of-Care (POC) diagnostics largely uses microfluidic technology for wide range of applications such as infectious diseases, molecular diagnostics, resource-limited settings, and chronic diseases. Recent advancements from researchers in the microfluidics aim to produce integrated devices that are automated, self-contained, rapid, and easy-to-use. As the United States has been a front-runner in technological advancements, the microfluidics market in the region expected to flourish at a prominent rate.
Key Players & Strategies
The global microfluidics industry witnesses intense competition among the market players as they are prominently investing in the new product advancement and development. This growth strategy helps the market participants to strengthen their footprint in the market and also in uplifting the position in the global market. For instance, in September 2019, Fluidigm Corporation introduced a novel microfluidics-based workflow i.e. Advanta RNA-Seq NGS Library Prep Kit that was designed for the preparation of RNA sequencing libraries.
Read Also: Vehicle-to-Grid Technology Market Size to Surpass US$ 17.43 Bn by 2027
Some of the prominent players in the microfluidics market include:
- Agilent Technologies, Inc.
- Illumina, Inc.
- Perkinelmer, Inc.
- Life Technologies Corporation
- Danaher
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd
- Abbott Laboratories
- Fluidigm Corporation
- Qiagen N.V.
- Thermo Fischer Scientific
- Biomérieux
- Cellix Ltd.
- Elveflow
- Micronit Micro Technologies B.V.
Segments Covered in the Report
By Material
- Glass
- Silicon
- PDMS
- Polymers
- Others
By Technology
- Non-Medical
- Medical
- Gel Electrophoresis
- PCR & RT-PCR
- ELISA
- Microarrays
- Others
By Application
- Organs-on-chips
- Lab-on-a-chip
- Continuous Flow Microfluidics
- Acoustofluidics and Microfluidics
- Optofluidics and Microfluidics
- Electrophoresis and Microfluidics
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Microfluidics Market, By Material
7.1. Microfluidics Market, by Material Type, 2023-2032
7.1.1. Glass
7.1.1.1. Market Revenue and Forecast (2021-2032)
7.1.2. Silicon
7.1.2.1. Market Revenue and Forecast (2021-2032)
7.1.3. PDMS
7.1.3.1. Market Revenue and Forecast (2021-2032)
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast (2021-2032)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2021-2032)
Chapter 8. Global Microfluidics Market, By Application
8.1. Microfluidics Market, by Application, 2023-2032
8.1.1. Organs-on-chips
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Lab-on-a-chip
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Continuous Flow Microfluidics
8.1.3.1. Market Revenue and Forecast (2021-2032)
8.1.4. Acoustofluidics and Microfluidics
8.1.4.1. Market Revenue and Forecast (2021-2032)
8.1.5. Optofluidics and Microfluidics
8.1.5.1. Market Revenue and Forecast (2021-2032)
8.1.6. Electrophoresis and Microfluidics
8.1.6.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Microfluidics Market, By Technology
9.1. Microfluidics Market, by Technology, 2023-2032
9.1.1. Non-Medical
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Medical (Gel Electrophoresis, PCR & RT-PCR, ELISA, Microarrays, Others)
9.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Microfluidics Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Material (2021-2032)
10.1.2. Market Revenue and Forecast, by Application (2021-2032)
10.1.3. Market Revenue and Forecast, by Technology (2021-2032)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Material (2021-2032)
10.1.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.1.4.3. Market Revenue and Forecast, by Technology (2021-2032)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Material (2021-2032)
10.1.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.1.5.3. Market Revenue and Forecast, by Technology (2021-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Material (2021-2032)
10.2.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.3. Market Revenue and Forecast, by Technology (2021-2032)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Material (2021-2032)
10.2.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.4.3. Market Revenue and Forecast, by Technology (2021-2032)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Material (2021-2032)
10.2.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.5.3. Market Revenue and Forecast, by Technology (2021-2032)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Material (2021-2032)
10.2.6.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.6.3. Market Revenue and Forecast, by Technology (2021-2032)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Material (2021-2032)
10.2.7.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.7.3. Market Revenue and Forecast, by Technology (2021-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Material (2021-2032)
10.3.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.3. Market Revenue and Forecast, by Technology (2021-2032)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Material (2021-2032)
10.3.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.4.3. Market Revenue and Forecast, by Technology (2021-2032)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Material (2021-2032)
10.3.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.5.3. Market Revenue and Forecast, by Technology (2021-2032)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Material (2021-2032)
10.3.6.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.6.3. Market Revenue and Forecast, by Technology (2021-2032)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Material (2021-2032)
10.3.7.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.7.3. Market Revenue and Forecast, by Technology (2021-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Material (2021-2032)
10.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.3. Market Revenue and Forecast, by Technology (2021-2032)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Material (2021-2032)
10.4.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.4.3. Market Revenue and Forecast, by Technology (2021-2032)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Material (2021-2032)
10.4.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.5.3. Market Revenue and Forecast, by Technology (2021-2032)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Material (2021-2032)
10.4.6.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.6.3. Market Revenue and Forecast, by Technology (2021-2032)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Material (2021-2032)
10.4.7.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.7.3. Market Revenue and Forecast, by Technology (2021-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Material (2021-2032)
10.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.5.3. Market Revenue and Forecast, by Technology (2021-2032)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Material (2021-2032)
10.5.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.5.4.3. Market Revenue and Forecast, by Technology (2021-2032)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Material (2021-2032)
10.5.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.5.5.3. Market Revenue and Forecast, by Technology (2021-2032)
Chapter 11. Company Profiles
11.1. Agilent Technologies, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Perkinelmer, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Life Technologies Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Danaher
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bio-Rad Laboratories, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hoffmann-La Roche Ltd
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Abbott Laboratories
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Fluidigm Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Qiagen N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Thermo Fischer Scientific
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Biomérieux
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Cellix Ltd.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Elveflow
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Micronit Micro Technologies B.V.
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
